Screening of pregnant women aged 40 years old and above for cardiac abnormalities using electrocardiography (ECG) to prevent maternal mortality
Malaysian Health Technology Assessment (MaHTAS)
Record ID 32016000304
English
Authors' objectives:
To reviewed evidence on the effectiveness, cost-effectiveness and safety on the use of ECG to screen cardiac
abnormalities in pregnant women age 40 years old and above to prevent maternal mortality.
Authors' recommendations:
There was no retrievable scientific evidence on the safety and cost-effectiveness on the use of ECG to screen cardiac abnormalities in pregnant women aged 40 years old and above.
There was one cross-sectional study conducted by Akinwusi et al. among healthy pregnant Nigerian women and non-pregnant women. The author reported cardiovascular and electrocardiographic changes found in these healthy pregnant Nigerian women. The study showed that, there were some distinctive ECG features which may help to differentiate cardiac disease in pregnancy from normal cardiac findings in our practice area. However, this is considered as fair level evidence which warrants high quality clinical research.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.moh.gov.my/index.php/database_stores/store_view_page/30/246
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Malaysia
MeSH Terms
- Humans
- Electrocardiography
- Female
- Heart Defects, Congenital
- Maternal Mortality
- Pregnancy
Contact
Organisation Name:
Malaysian Health Technology Assessment
Contact Address:
Malaysian Health Technology Assessment Section, Ministry of Health Malaysia, Federal Government Administrative Centre, Level 4, Block E1, Parcel E, 62590 Putrajaya Malaysia Tel: +603 8883 1229
Contact Name:
htamalaysia@moh.gov.my
Contact Email:
htamalaysia@moh.gov.my
Copyright:
Malaysian Health Technology Assessment (MaHTAS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.